Youngblood develops antimicrobial surface technology

Jeffrey Youngblood, MSE Professor

New technology, marketed commercially as Nouvex, and developed by Professor Jeffrey Youngblood, changes the composition of injected-molded products, giving them the ability to destroy pathogens on contact. We hope this partnership and technology take off.  It is really timely during the current pandemic.

Learn more: